Cerity Partners’s Amgen AMGN Stock Holding History

Cerity Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$106K	Buy	+300	New	+$107K	﹤0.01%	3020

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cerity Partners's AMGN Position: Q1 2026 in Review

Cerity Partners increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $7.73M and bringing the position to 433,555 shares worth $153M. The position accounts for 0.22% of the portfolio, ranked #95.

Cerity Partners first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $153M in Q1 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Cerity Partners held 433,555 shares of Amgen worth $153M as of Q1 2026.
Cerity Partners bought 21,682 Amgen shares in Q1 2026, an estimated $7.73M.
Amgen made up 0.22% of Cerity Partners's portfolio in Q1 2026, its #95 holding.
Cerity Partners first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
Cerity Partners's Amgen position peaked at $153M in Q1 2023.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.